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Introduction 
TATA-binding protein (TUP) is a major component of 
the transcription factor II11 (TFIID) found in all man- 
malian cells [1,2]. The association of TFIID with the 
TATA box is the first step in the formation of a transcrip- 
tion complex that can initiate the synthesis of ml<NA 
[X-7] Recent studies suggest that recruitment ofTBP to 
the promoter can be a rate-limiting step for transcription 
ir/ viw and that interaction of TBP with the activation 
domains of other transcription factors may stabilize the 
binding ofTBP to the promoter [8,9].TUP is highly con- 
served in eukaryotic organisms and is one of the most 
intensively studied proteins involved in transcriptionThe 
shape of the carboAT-terminal portion ofTUP resembles a 
saddle cousisting of two roughly symmetric halves [lo]. 
The inner surface of the saddle interacts with the minor 
groove of the TATA cequence, causing striking distortions 
in DNA [ 1 l-131. The minor groove of the TATA box is 
[Tidened and flattened and interacts with the whole 
concave underside of the molecular saddle through a 
variety of hydrophilic and hydrophobic contacts 13, IO]. 
As a consequence of this unprecedented mode of interac- 
tion between a DNA-binding protein and DNA, the 
entu-e TATA box is severely bent through an angle of 
about 80 toward the major groove, with an associated 
unminding of the TATA box of about 100. [ 1 l-l 31. 
Despite the detailed structural analysis of TBP and the 
TUI’-TATA box complex, several important features 
remain to be examined. Among these are the question of 
how TUP binding affects the structure of the regions that 
flank the TATA box and the structural origin of the 
asynirnetry that follows initiation of transcription at the 
3’-side of the TATA box, as a result of binding of an 
almost symmetric protein. We wished to explore the pos- 
sibility that the asymmetric effect ofTBP binding to the 
TATA sequence might be due to a transient unwinding 
occurring preferentially to the downstream side of the 
TATA box. We therefore designed experimeuts with 
pluramycin, which should preferentially intercalate in 
uuwouud LINK sites. Thus, dynamic effects propagated 
preferentially to one side or the other of the TATA box as 
a consequence of the TBl’-iuduced unwinding of the 
TATA site can be monitored. Pluramycin (Fig. la) is a 
member of the family of anthraquinone-derived anti- 
tumor antibiotics, which are broadly characterized as 
DNA-threading intercalation agents (Fig. 1 b) [14-l 81. In 
addition to their intercalation properties, these drugs also 
form covalent adducts with N7 of guanine, which upon 
heat treatment give rise to DNA strand breakage products 
[ 151, thus revealing their site of intercalation (Fig. 1 c). 
Results 
Specific and nonspecific binding of hTBP to DNA containing 
a TATA box 
A DNase I protection assay was carried out initially to 
monitor the kinetics of formation of the human TBP 
(hTBI’)-TATA box complex using a G-base-pair (bp), 
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double-stranded oligonucleotide (64M) (see Fig. 2) con- 
taining the muscle-specific promoter of the human myo- 
globin gene [19,20].As illustrated in Figure 3a (lanes 2 and 
lo), the TATA box (5’-TATAAAAA) was completely pro- 
tected from DNase I digestion in the absence of competi- 
tor DNA, and a region exterior to the TATA box was also 
weakly protected by hTBP (see brackets to the right of 
lane 10 in Figure 3a, denoting specific and nonspecific 
hTBP binding). To quantitate the affinity of hTBP for the 
flanking region of the TATA box (nonspecific binding) 
and for the TATA box region (specific binding), unlabeled 
template DNA (40 molar excess) was added to each reac- 
tion, and the dissociation of the hTBP-DNA complex was 
analyzed by DNase I footprinting after various intervals. 
The autoradiogram in Figure 3a was scanned by an LBK 
laser scanner, and the fraction of the specific and nonspeci- 
fic hTBP-DNA complexes was calculated to determine 
the dissociation rates of the hTBP-DNA complexes in 
solution. By plotting the natural log of the fraction of 
probe DNA bound versus time, the first-order dissociation 
rate constants were calculated (Fig. 3b). As expected, the 
nonspecific complex between hTBP and the flanking 
regions of the TATA box was much less stable, with a half- 
life of 10 min, while the specific complex between hTBP 
and the TATA box region was much more stable, with a 
half-life of 120 min. The dissociation rate constants for the 
specific and nonspecific hTBP-DNA complexes in solu- 
tion were calculated to be 8.9 x 10-j s-l and 2.6 x lop3 
SC’, respectively. The -30-fold difference in dissociation 
rates for the two types of hTBP binding sites provides evi- 
dence for both a class of weak, nonspecific binding sites 
between hTBP and the TATA binding region and a class 
of stronger, specific binding sites that have also been found 
with yeast TBP (yTBP) [21]. A similar pattern of protec- 
tion was also observed with yTBP (unpublished results), 
but in this case, a region exterior to the TATA box was 
more weakly protected by yTBP compared to hTBP 
Furthermore. the nonspecific complex between yTBP and 
Fig. 1. Pluramycin as a probe of DNA 
accessibility. (a) Structure of plura- 
mycin. (b) Solution conformation of 
the pluramycin(N7guanine) DNA 
adduct showing the intercalated 
moiety side chain at C2 (white), which 
undergoes reaction with N7 of guanine 
(cyan), and the sugars at 03 and Cl0 
(yellow), which interact within the 
minor groove of DNA [181. (c) 
Mechanisms for the covalent reaction 
of pluramycin with DNA and the heat- 
induced strand breakage of the plura- 
mycin-(N7-guanine) DNA adduct 1151. 
The multiplicity of bands in Figs 3, 4, 
and 6 for each alkylation site are due 
to incomplete chemical degradation, 
which gives rise to both species A and 
B. Species A can be converted to 
species B with piperidine treatment. 
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Fig. 2. Sequences of oligonucleotides 
used in these studies. 64M is the 
sequence of the muscle-specific pro- 
moter of the human myoglobin gene. In 
oligonucleotide 64MI, the highlighted 
nucleotides flanking the TATA box are 
altered. The TATA sequence is boxed. 
the flanking regions of the TATA box was much less stable box. The effect of hTBP binding to the TATA box on 
than the nonspecific complex formed by hTBP, in agree- both the DNase I cleavage and pluramycin modification 
ment with the observations made by Hawley and col- patterns is shown in Figure 4. In the absence of hTBP 
leagues [21]. We speculate that the amino terminus of binding to the TATA box, pluramycin produces highly 
hTBP may be important in modulation of nonspecific reactive bonding sites on both sides of the TATA box (see 
complex formation, since the carboxyl terminus is highly lanes 4 and 5 in Fig. 4a and arrows, which correspond to 
conserved between yTBP and hTBP [lo-l 31, while the alkylated guanines). However, in the presence of hTBP 
amino-terminal region varies considerably in length and in the pluramycin alkylation site immediately downstream of 
primary structure in different species [22] .To eliminate the the TATA box shows enhanced cleavage, while alkylation 
nonspecific binding complex between hTBP and DNA of sites adjacent to the 5’-side of the TATA box is severely 
in subsequent experiments, an excess of unlabeled com- inhibited (compare lanes 4 and 6 and lanes 5 and 7 in Fig. 
petitor DNA was added to the preformed hTBP-DNA 4a). The pluramycin modification pattern in the absence 
complex, and the reactions were incubated for 10 min and presence of hTBP on the other strand is shown in 
before further experimentation. Figure 4b (lanes 4 and 5, respectively). In contrast to the 
top strand, significantly enhanced pluramycin alkylation 
Effect of specific binding of hTBP to the myoglobin TATA box 
on pluramycin modification of 64M 
Pluramycin was used as a probe to identify possible 
unwinding sites generated by hTBP binding to the TATA 
sites are not evident, and alkylation of the guanine imme- 
diately adjacent to the downstream site of the TATA box 
is not significantly inhibited. The unique reactivity of this 
downstream site is clearly related to the binding ofTBP to 
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Fig. 3. Formation of specific and nonspecific complexes of hTBP with 64M. (a) DNase I footprinting. hTBP-DNA complexes were 
formed as described in Materials and methods and incubated for various periods of time (shown in the figure heading) in the absence 
(lanes 2 and 10) or presence (lanes 3-9) of unlabeled competitor DNA. For the footprinting analysis, 20 ~1 of the sample was removed, 
added to DNase I, and incubated an additional one min at 37 “C. The DNase I reactions were quenched with alkaline dye and 
processed for analysis on a sequencing gel. Brackets on the right-hand side of the gel show regions of specific and nonspecific hTBP 
binding. (b) Dissociation rates of the specific (-A-) and nonspecific (a-) complexes in solution. The natural log (In) of the fraction of 
the DNA bound to hTBP is plotted against time (min). The first-order dissociation rate constants, calculated as the negative of the 
slopes, were determined to be 8.9 x 1 Om5 5-l and 2.6 x 1 O-3 s-l for the specific and nonspecific complexes, respectively. 
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Fig. 4. Effect of soecific hTBP bindine ” 
to”the TATA box 0; the pattern of plura- 
mycin modification of 64M on the (+) 
and (-1 strands. The specific hTBP-DNA 
complex was formed as described in 
Materials and methods and modified 
with pluramycin for 5 min. Drug modi- 
fication was terminated by adding 
100 ~1 of double-distilled water (DDW) 
containing 10 ~g of calf thymus DNA 
followed by heating the reactions at 
95 “C for 15 min to induce DNA strand 
breakage at the drug modification sites 
[15]. Lanes 1 and 2 of (a) [(+) strand] 
and (b) [(&I strand] are DNase I foot- 
printing without and with hTBP, respec- 
tively. For (a), lanes 4 and 6 contained 
100 nM of pluramycin (final concentra- 
tion) and lanes 5 and 7 contained 400 
nM of pluramycin. Drug modification 
was carried out for a period of 5 min. 
For (b), lanes 4 and 5 contained 
400 nM of pluramycin. 
the TATA box, as is the dampened reactivity of the other 
sites on both sides of the TATA box. To determine if 
sequence context could change the pattern of enhanced 
and diminished reactivity, a second sequence (64MI), in 
which the flanking sequences to the TATA box were 
different, was also tested for this asymmetric pattern of 
pluramycin modification in the presence of hTBP 
Effect of multiple pluramycin intercalation sites on both 
sides of the TATA box 
Although the natural myoglobin muscle promoter TATA 
sequence was useful in that it provided a result sugges- 
tive of a downstream side-specific effect ofTBP binding 
on pluramycin intercalation, it suffered from three 
potential drawbacks. First, a previous study on the 
sequence selectivity of pluramycin [ 161 has revealed that 
pluramycin prefers the 5’-CG* sequence to the 5’-AG*, 
5’-TG*, and 5’-GG* sequences (* indicates the plura- 
mycin modification site). Therefore, we could not 
exclude the possibility that the absence of 5’-CG* 
sequences on the upstream side of the TATA box might 
affect the overall efficiency of pluramycin modification 
in that region. Second, the enhanced pluramycin reactiv- 
ity site might be a function of a special sequence context 
in proximity to the binding of hTBP to the TATA box. 
Third, this natural sequence did not reveal whether the 
effect was also specific for a site at a predetermined dis- 
tance from the TATA box, in addition to being selective 
for the downstream side. Therefore, a new DNA tem- 
plate was designed in which repetitive 5’-CG* sequences 
were included on both strands of the upstream and 
downstream sides of the TATA box in order to map pre- 
cisely the hTBP-induced intercalative high-reactivity 
sites for pluramycin (see 64MI in Fig. 5d). Figure 5a,b 
shows an experiment similar to that shown in Figure 4 
using the new DNA template. Pluramycin showed 
enhanced intercalation/alkylation reactivity with only a 
single site (c* in Fig. 5c), which is located on the down- 
stream side of the TATA box. Other sites (d, e, f, i, j and 
k) on the downstream side showed diminished reactivity 
or, in one case (h), similar reactivity. Significantly, site ‘h’ 
is located on the other side of the pluramycin intercala- 
tion site, which shows enhanced reactivity on the other 
strand (site c, Fig. 5~). Sites on the upstream side (a, b, 
and g) all showed reduced reactivity (see Fig. 5~). 
Therefore, the results using the natural myoglobin 
muscle enhancer sequence (Fig. 4) and those using the 
artificial sequence containing multiple CG* sites for 
pluramycin modification are entirely consistent and 
reveal that binding of hTBP to the TATA box results in 
enhancement of pluramycin intercalation/reactivity that 
is specific for the downstream ride of the TATA box and 
for a site immediately to the 3’-side of the TATA box 
(both results are summarized in Fig. 5d). In addition, a 
common site on the opposite strand, which is located on 
the other side of the pluramycin intercalation site in 
both 64M and 64M1, shows negligible changes in alkyla- 
tion reactivity. Therefore, these results suggest that it is 
unlikely that these common sites of enhanced or similar 
pluramycin reactivity in 64M and 64MI are due to 
either a structural consequence of a specific sequence 
context or the inherent sequence selectivity of plura- 
mycin, but they are in accord with a common unwind- 
ing site at this 5’-CC sequence, resulting from TBP 
binding to the adjacent sequence. 
Effect of pluramycin modification on conversion of 
nonspecific to specific hTBP-TATA-box complexes 
Since hTBP binding to the TATA box creates a high reac- 
tivity intercalation site for pluraniycin, it was important to 
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determine how pluramycin would affect conversion of 
nonspecific to specific hTBP-DNA complexes. A gel 
mobility shift assay was used to monitor the conversion of 
nonspecific to specific hTBP complexes at 37 “C by adding 
a %-molar excess of unlabeled competitor DNA and 
drawing aliquots at various times, which were then imme- 
diately loaded onto a native gel at 4 “C.Three parallel incu- 
bations were carried out without drug (control) or with 
pluramycin or (+)-CC-l065 (a minor-groove adenine N3 
alkylating agent) added at the same time as competitor 
DNA.The results in Figure 6a (graphically represented in 
Fig. hb), show that in the presence of pluramycin the 
amount of conversion of the nonspecific to the specific 
complex was significantly increased compared to a control 
experiment without pluramycin (compare left and middle 
panels).This is in sharp contrast to an experiment in which 
the conversion to the specific complex was almost com- 
pletely inhibited in the presence of (+)-CC-1065 [23], 
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Fig. 5. Effect of specific hTBP binding to the TATA box on the pattern of pluramycin modification of the 64MI DNA template on the 
(+) and (-) strands. The specific hTBP-DNA complex was formed as described in Materials and methods, and 200 nM of pluramycin 
(final concentration) was incubated with the reaction mixture for 5 min. Pluramycin modification was stopped by adding 100 ~1 of 
DDW containing 10 kg of calf thymus DNA followed by phenol/chloroform extraction and ethanol precipitation. DNA pellets were 
dissolved in 20 ~1 of 1 M piperidine solution, and samples were heated at 95 “C for 15 min to induce strand breakage at drug modifi- 
cation sites, as described in Materials and methods. The pattern of pluramycin protection on the (+) strand (a) and (&) strand (b) of 
oligomer DNA 64MI. The sequences to the left and right of (a) and (b) show the sequence of the TATA element and pluramycin alkyla- 
tion sites on both sides of the TATA box, respectively. (c) Pairs of densitometer scans of lanes 4 and 5 from (a) and (b) of this figure. 
Inside scans are in the absence (-) and outside scans are in the presence (+) of TBP. Sites ‘a’ through ‘k’ are pluramycin alkylation 
sites (the asterisk shows the pluramycin-enhanced site). The TATA box is enclosed in a rectangle. (d) Schematic representation of 
pluramycin enhancement, no change, and protection sites on a portion of oligomer DNAs 64M and 64MI. The yellow dots indicate 
sites of inhibition, solid red arrows indicate sites of enhancement, dotted red arrows indicate no change, and the blue arrows indicate 
sites of phenylalanine insertion. The dinucleotide numbering system used later in the paper is noted above the sequence. 
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presumably due to the selective modification of the minor 
groove of the TATA box by (+)-CC-1065 (see right panel; 
our unpublished data). 
Subsequently DNA was isolated from both the unbound 
and the hTBP-bound samples (I and II in Fig. 7a), and 
the thermal strand-breakage assay was then used to 
determine the extent and the site selectivity of plura- 
mycin modification in both samples of DNA on the (f) 
and (-) strands (Fig. 7b). In accord with previous experi- 
ments, this assay reveals that pluramycin modification is 
specifically enriched at the two adjacent guanines on 
opposite strands immediately to the downstream side of 
the TATA box in the specific hTBP-bound DNA 
(compare lanes B and F in Figure 7b for both the (f) 
and (-) strands). 
To obtain further evidence for the increased conversion 
of nonspecific to specific complexes in the presence of 
pluramycin, the effect of increasing quantities of drug 
in the incubation mixture on the amount of the spe- 
cific hTBP-DNA complexes was analyzed by the gel 
mobility shift assay.The results shown in Figure 8 indi- 
cate that as the concentration of pluramycin is 
increased, the amount of the hTBP-DNA complex also 
increases, In a parallel experiment, the pluramycin- 
modified DNA was recovered from the hTBP-DNA 
complexes, and the thermal strand-breakage assay was 
then used to monitor the extent of pluramycin modifi- 
cation. This result also shows a positive correlation 
between the extent of pluramycin modification at the 
downstream sites and the amount of conversion of 
nonspecific to specific hTBP-DNA complexes (data 
not shown). 
Pluramycin modification of downstream sites increases the 
stability of the hTBP-DNA complex 
A direct comparison of the stability of the hTBP-DNA 
complex in the absence and presence of pluramycin 
specifically bound at the downstream enhancement sites 
was made by determining the dissociation rate of the 
respective specific hTBP-DNA complexes (left and right 
panels of Fig. 9, respectively); both experiments were 
carried out in the presence of excess nonlabeled com- 
petitor DNA.The results in the right panel show that in 
the presence of pluramycin the specific hTBP-TATA 
box complex is quite stable, at least up to 120 min. In 
contrast, about a 50 % dissociation of the complex 
occurred in the absence of pluramycin during the same 
period of time, based upon the densitometric measure- 
ments of the specific complex (unpublished results). 
Therefore, intercalation of pluramycin into the region 
immediately downstream of the TATA box considerably 
stabilizes the specific hTBP-DNA complex. 
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Fig. 6. Effect of pluramycin and (+)-CC- 
1065 modification of 64M on the conver- 
sion of the nonspecific to the specific 
binding complex between hTBP and the 
TATA box. The hTBP-DNA complexes 
were formed at 37 “C in a final volume of 
100 ~1, as described in Materials and 
methods. (a) A 20-fold excess of cold- 
template DNA was added to reactions 
without (left panel) or together with 
400 nM of pluramycin (center panel) or 
200 nM of (+)-CC-l 065 (right panel). At 
the indicated times (min), the extent of 
hTBP-DNA complex formation was 
determined by a band shift analysis. A 
sample (5 ~1) of the reaction was loaded 
onto the gel and separated by elec- 
trophoresis at 4 “C. Lane 1 shows a 
control reaction without hTBP, lane 2 
shows an hTBP-DNA complex in the 
absence of competitor DNA, and lanes 
3-7 are incubation with cold-template 
DNA for the indicated times before 
loading on the gel. (b) The left and center 
autoradiograms shown in (a) were 
scanned with a densitometer and the per- 
centage of specific complex formed was 
plotted against time (-•, control; -0-, 
incubated with pluramycin). 
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Fig. 7. Determination of the extent and sites of pluramycin modification in unbound and TBP-bound oligonucleotides. (a) Gel elec- 
trophoretic isolation of the pluramycin-modified specific hTBP-64M complex after modification with pluramycin. The specific 
hTBP-DNA complex was formed as described in Materials and methods. After addition of 20 molar excess of unlabeled competitor 
DNA, the reaction was incubated for a further 10 min, modified with 200 nM of pluramycin for 5 min, and loaded onto a 5 % 
polyacrylamide gel to separate the hTBP-64M complex from the free 64M. Lanes 1 and 3 correspond to (+) strand-labeled template 
DNA and lanes 2 and 4 correspond to (-) strand-labeled template DNA (I and II refer to the free 64M and hTBP-64M complexes, respec- 
tively). (b) Determination of the site of pluramycin modification on the (+) and (-) strands of 64M recovered from the specific hTBP-DNA 
complex. DNA molecules corresponding to bands I and II in (a) from the (+) and (-) strands were recovered from the gel (see Materials 
and methods) and subjected to the thermal strand-breakage assay 1151. Lane headings ‘F’ and ‘B’ refer to the free 64M and hTBP-64M 
complexes, respectively, obtained from lanes 3 I(+) strand] and 4 I(-) strand]. The sequence to the right of the (+) and i-) strands shows 
the pluramycin alkylation sites (denoted with an asterisk) on the downstream side. 
Pluramycin modification stabilizes the hTBP-induced 
bending and unwinding of DNA 
In previous studies, the ability ofTBP to bend DNA has 
been demonstrated by means of a gel mobility shift assay 
and crystallographic observation [ 1 l-l 3,241. In this 
study, the stability of the hTBP-induced DNA bending 
and unwinding was examined by studying the efficiency 
of cyclization of multimers of a 53-bp oligomer DNA 
fragment containing the TATA box, carried out in the 
presence ofT4 DNA ligase. Significantly, no net change 
in the linking number occurs because the unwinding is 
offyet by changes in writhing 1251. As shown in Figure 
lOa, in the presence ofT4 DNA ligase, the 53-bp DNA 
fragment formed a set of linear dimers, trimers, and 
tetramers (L2, L3 and L4) and closed circular trimers 
(C3) but was not converted into covalently closed cir- 
cular dimers (C2). However, upon the addition of hTBP 
at a protein to DNA ratio of 3 to 1, circular dimers (106 
bp) appeared among the ligation products. In subse- 
quent experiments, the effect of pluramycin modifica- 
tion on the efficiency of the formation of circular 
dimers was examined. Pluramycin modification of DNA 
(Fig. IOc, lanes 5 and 6) increased the number of circu- 
lar dimers; only one third of the amount of hTBP was 
required to produce the same amount of C2. These 
results support the idea that pluramycin modification of 
guanine residues at the 3’-side of the TATA box stabil- 
izes a specific binding mode of hTBP to DNA by 
forming a stably unwound form of DNA adjacent to 
the hTBP binding site.This result also suggests that the 
specific binding mode of the hTBP-TATA box 
complex that is stabilized by pluramycin has no net 
change in bending unless additional writhing occurs to 
compensate for this. 
Discussion 
The main purpose of this study was to use pluramycin as 
a molecular probe to determine the effects of hTBP 
binding on local DNA structure and the dynamics of the 
event in the vicinity of the TATA box. Pluramycin 
belongs to the anthraquinone-derived antitumor anti- 
biotic family, which also includes the altromycins, 
hedamycin, and rubiflavin (for review, see [14]). In a 
recent study, Beerman and colleagues [2h] used 
hedamycin as a DNA interactive agent to examine how 
drug modification of DNA affects TBP binding. Their 
study shows inhibition ofTBP binding to the adenovirus 
major late promoter.This finding is not in conflict with 
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(a) Cl23456789 
Fig. 8. Determination of the effect of increasing concentrations 
of pluramycin on the formation of the specific hTBP-DNA 
complexes using a gel shift assay. (a) hTBP-DNA complexes 
were formed as described in Materials and methods, and a pre- 
determined amount of pluramycin was added to each of the 
incubations. After incubation for 30 min, the amounts of the 
specific hTBP-DNA complexes were determined by densitome- 
ter scans of individual lanes. Lane C, control (in the absence of 
hTBP). Lanes l-9 contained hTBP plus 0, 0.2, 0.3, 0.4, 0.5, 
0.6, 0.8, 1.0 and 1.2 mM, respectively, of pluramycin. (b) 
Histogram of the percentage of the specific complex plotted 
against the concentration of pluramycin determined from (a). 
the results reported here, because binding of hedamycin 
to the guanine (G*) dj a ‘acent to the 3’-side of the TATA 
box in this promoter (5’-TATAAAAG*GG) blocks the 
insertion of the amino-terminal pair of phenylalanine 
residues into the ApG dinucleotide, presumably resulting 
in the prevention of TBP-DNA complex formation. 
We have recently shown that these antibiotics interact 
with DNA in a threading intercalating mode, but they 
also alkylate N7 of guanine with a sequence specificity 
that lies to the 5’-side of the covalently modified 
guanine [ 14-181. As a requirement for pluramycin reac- 
tion with DNA, the helix must be unwound and the 
minor groove must be accessible to the sugar moieties of 
pluramycin (see Fig. lb). Pluramycin has a critical 
advantage over other, better known unwinding probes 
such as MPE.Fe(II) or Cu-phenanthroline as a molecu- 
lar probe for protein-induced unwinding of DNA, 
because it forms a stable covalent attachment at the 
intercalation site.The other agents hit and run, leaving 
Pluramycin 
C 40 90 120 (min) C 40 90 120 (min) 
Specific II)* .l* complex 
FIW 
DNA 
Fig. 9. Dissociation kinetics of the specific hTBP-DNA complex 
in the presence (right panel) or absence (left panel) of plura- 
mycin, determined by a gel mobility shift assay. Using the plura- 
mycin-modified DNA (right) or unmodified DNA (left), 
hTBP-DNA complexes were formed as described in Materials 
and methods. To determine the dissociation rate of the 
hTBP-DNA complex, a 40.molar excess of unlabeled competitor 
DNA was added to the reactions, which was then incubated for 
the indicated periods of time shown in the lane headings. The 
residual amount of the specific hTBP-DNA complex at various 
time intervals was analyzed by gel mobility shift assay (see text). 
strand breaks at the intercalation site. Although in previ- 
ous studies using DNase I, MPE.Fe(II) and Cu-phenan- 
throline, the area protected by TBP extended beyond 
the base pairs normally considered part of the TATA 
box consensus sequence [27-291, these footprinting 
methods generally did not reveal the relative importance 
of individual bases in the interaction with the protein or 
altered DNA structure upon TBP binding to the TATA 
box. Moreover, the demonstrated compatibility of plura- 
mycin intercalation with hTBP binding to the TATA 
box and the increased stability of the ternary complex 
could not have been determined with these strand 
breakage reagents. 
In this study we demonstrate that hTBP binding to the 
TATA box creates an enhanced pluramycin intercalation 
site immediately downstream of the TATA sequence. 
This results in increased covalent reactivity with one of 
the guanines flanking this intercalation site (see Figs 4, 
5d).This result is surprising, since in the crystal structures 
ofTBP bound to DNA solved by both Burley and col- 
leagues [12] and Sigler and colleagues [l l], there is no 
indication of a deformation of DNA at, or adjacent to, 
the enhanced pluramycin reactivity/intercalation site. In 
fact, at the 8-9 and 9-10 dinucleotides (pluramycin 
intercalates between base pairs 9 and IO, numbered with 
the first T of TATA as nucleotide 1; see Fig. 5d), the co- 
crystals show B-form DNA. Therefore, we propose that 
pluramycin is detecting a transient unwinding effect 
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Fig. 10. (a) Effect of incubation with 
hTBP on the T4 ligase-catalyzed con- 
version of a 53.bp oligonucleotide to 
dimer l(%bp circles. Ll-LS indicate 
linear monomer to linear pentamer, and 
C2 and C3 indicate circular dimer and 
circular trimer DNA. Lanes C and P 
represent the ligation products without 
and with three molar excess of hTBP in 
the reaction. (b) Denaturing gel analy- 
sis of the DNA species ILI-L5 and 
CZ-CS) isolated from the gel shown in 
(a). For DNA molecules designated as 
C2 and C?, bands a, b and c represent 
linear, circular single-stranded and 
undenatured DNA species, respectively 
1361. (c) Effect of pluramycin modifica- 
tion on the efficiency of hTBP-induced 
cyclizntion. Lanes 1 and 3 show control 
reactions without hTBP and lanes 2 and 
4 represent ligation with three- and 
one-molar excesses of hTBP, respec- 
tivcly. Lanes 5 and 6 contain 2 and 5 ng 
of pluramycin, respectively, in addition 
to hTBP at a one-molar excess. (d) 
Sequence of the .53-bp oligonucleotide 
used in the cyclization experiments. 
The bar indicates the TATA box consen- 
sus sequence, and the flanking A5 
tracts are underlined. 
(a) (b) (d 
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rather than a stable structural change in this region, and 
this is ascociatrd with hTBP binding to the adjacent 
TATA box. It is important to differentiate between the 
possibility that enhanced reactivity of pluramycin at this 
site is a direct effect of a stable change in minor groove 
geometry at the upstream base pair, providing an 
increased proximity effect at the alkylation site, and the 
possibility that the indirect unwinding effect is transient 
and related to the adjacent binding of hTBP to DNA. 
We believe the former explanation, involving a favorable 
n~inor-t:roove geometry change, is unlikely because this 
would be revealed in the X-ray studies. It would also be 
sequence dependent, and therefore should result in sites 
of enhancement that would vary with the different 
flanking sequences (such as in 64M and h3MI). This is 
cledrlv not the case , since the site of pluramycin- 
enhanced reactivity occurs at just one defined position 
relative to the TATA box, irrespective of sequence 
context. On the contrary, this observation argues for a 
source that is common to both the NM and &%MI 
sequences (that is, the TBI’-5’-TATAAAAA sequence 
complex) and i\ independent of sequence context. 
We propose that the enhanced pluramycin reactivity is 
due to a transient unwinding effect occurring specifically 
at the 9-10 dinucleotide step that stabilizes pluramycin 
intercalation at this site. This proposal is consistent with 
the enhanced reactivity at site ‘c’ and no change in reac- 
tiviq at site ‘h’ (Fig. 5c) and the corresponding plura- 
mycm reactivities shown in Figure 4. Furthermore, 
pluramycin intercalation adjacent to the hTBP-TATA- 
box complex appears to be associated with a ‘specific’ 
binding mode that stabilizes a ternary complex in which 
compensatory alterations occur in DNA induced by both 
ligands.This conclusion is further supported by competi- 
tion experiments showing the enrichment of DNA 
specifically modified by pluramycin at the enhancement 
site in specific hTBP-TATA box complexes and by the 
increased efficiency of circularization of the C2 species in 
the presence of pluramycin demonstrated in the ligation 
experiments. Last, in order to determine directly the 
effect of flexibility of adjacent base pairs to pluramycin 
alkylation, we have determined the relative reactivity of a 
site having a one-base bulge to the 5’-side of the interca- 
lation/guanine alkylation site for pluramycin. Such one- 
base bulges dramatically increase the covalent reactivity of 
the adjacent guanine to pluramycin (10 to 100 times 
greater reactivity) (S.-J. Lee, M. Hansen and L.H.H., 
unpublished results). This is consistent with the proposal 
presented here that the adjacent binding of hTBP pro- 
duces an unwinding of the CG dinucleotide and, thus, 
enhanced reactivity of pluramycin. 
The dynamic effects of pluramycin modification of the 
region immediately downstream of the TATA box on the 
hTBP-DNA complex are also very informative. 
Pluramycin binding to this downstream region causes an 
increased conversion of nonspecific to specific complexes 
and a pronounced stabilization of the specific 
hTBP-DNA complex (in the absence of pluramycin, the 
half-life is 120 min, whereas in the presence of plura- 
mycin, no significant dissociation was found during the 
same time period; see Fig. 9). Most likely, the enhanced 
stabilization (and -. . 1, Llrcu arlzation efficiency) of the 
hTBP-DNA complex by pluramycin intercalative 
binding is due to stabilization of a ‘specific’ binding 
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mode, resulting in compensatory alterations in DNA 
structure produced by both ligands. 
Structure of the pluramycin-TBP-TATA-box 
Based upon the X-ray structure of the TBP-TATA box 
complex [ll-131, the NMR solution structure of the 
pluramycin-DNA complex [18], and the enhanced 
covalent reactivity site for pluramycin in the 
hTBP-DNA complex shown here, a molecular 
model for the ternary structure of the plura- 
mycin-hTBP-DNA complex was constructed (Fig. 
11). Docking of the covalently bound pluramycin in an 
unwound site at the 9-10 position, so that alkylation 
occurs at site ‘c’ (Fig. 5c), did not produce any steric 
clashes between pluramycin and TBP After minimizing 
in vucuo, Lys97 forms an H-bond with a phosphate 
flanking the pluramycin binding site on the minor- 
groove side and the 0-acetyl group of pluramycin, but 
this may be an artifact of the in vucuo minimization 
(Fig. lla). It is intriguing that the major-groove side of 
the pluramycin intercalation site is wide open for inter- 
action with other components of the transcriptional 
activation system, and if the 9-10 dinucleotide was 
unwound, it could be captured by an appropriately 
positioned aromatic moiety (Fig. 1 lb). 
Implications of hTBP-induced pluramycin intercalation for 
nucleation of unwinding by hTBP 
An important unanswered question related to the 
binding ofTBP to the TATA box is how nucleation of 
unwinding is achieved in an asymmetric manner [30]. 
The TBP molecule has an approximate two-fold sym- 
metry axis, and furthermore, its interactions with the 
TATA box are all matched in the two protein subdo- 
mains [l l-131. In contrast, the TATA binding sequence 
is asymmetric by virtue of indirect readout of sequence 
information, with the 5’ half being more flexible, due to 
the alternating A’s and T’s, whereas the 3’ half, consisting 
of an A4 tract, is much more rigid.As has been proposed 
by Sigler and colleagues [l 11, this would result in an 
increased amount of energy required for deformation of 
the 3’ run ofA’s relative to that required for deformation 
of the TATA region. An apparent consequence of this 
sequence asymmetry in the TATA region is the induc- 
tion of high-reactivity pluramycin alkylation sites specif- 
ically at a site on the downstream side of the TATA box 
upon binding ofTBP 
How this induction of asymmetry from the TATA 
sequence to the downstream site identified by plura- 
mycin is transmitted by TBP binding is still not clear. The 
results from this study suggest that a transient unwinding 
effect, rather than a direct sequence recognition medi- 
ated by a changed groove geometry, is responsible for the 
increased alkylation reactivity. Conceivably, this transient 
unwinding is due to a redistribution of torque energy 
initially trapped by TBP binding to the unwound TATA 
box. Unwinding of the TATA box as a result of TBP 
binding might take place in a two-step process (that is, 
first the 5’-TATA side, then the 3’-side A-tract) and 
during dissociation is then released stepwise in the 
reverse two-step mode. If this proposal is true, then at an 
intermediate step in the TBP dissociation process a 
favorable transition of torque energy and associated 
unwinding might be released specifically to the down- 
stream side. This would create the unwound site inter- 
cepted by pluramycin intercalation. That this transient 
unwound state of the TBP-TATA-box complex is a spe- 
cific binding mode is suggested by the stability studies on 
the ternary complex and the circularization efficiency 
experiments. Based upon these observations and the 
model of the pluramycin-TBP-TATA-box complex 
(Fig. 1 l), in which the unwound site is accessible via the 
major groove to other proteins involved in transcrip- 
tional activation, it is tempting to suggest that the inter- 
calation site trapped by pluramycin might also be the 
nucleation site for the transcriptional start, which might 
be recognized by a planar aromatic moiety of a protein 
binding to this region. 
A number of precedents exist for protein-induced dis- 
tortion involving underwound regions of the helix. The 
case most relevant to the example described here is the 
transcriptional activation by the metal-responsive gene- 
regulatory protein (MerR) in the presence of nano- 
molar concentrations of mercuric ions [3 11. The result 
of the addition of Hg is the conversion of the RNA 
polymerase complex from the closed conformation to 
the strand-separated, transcriptionally competent open 
complex. In parallel with the observations described 
here, an Hg-MerR-induced structural alteration in the 
promoter has been detected by the intercalation-sensi- 
tive reagents MPE and Cu-phenanthroline [31]. In this 
case, the origin of the asymmetry does not appear to be 
the MerR binding site, since this is palindromic, but 
may be induced by the asymmetric interaction of Hg 
with the MerR. 
We would like to consider the biological implications of 
the immobilization of an intercalation agent like plura- 
mycin at a site of protein-induced distortion of DNA. 
One of us has previously proposed that the biologically 
important lesions for DNA-reactive drugs like the 
pluramycins and CC-1065 result from special niches 
produced on DNA as a consequence of protein- 
induced distortion of DNA [32,33]. We have now 
documented two such examples, the one described here 
and the Spl-induced bending sites that occur in the 21- 
bp repeat region of SV40 DNA, which maintains high- 
reactivity sites for CC-1065 between GC boxes III and 
IV andV andV1 [34]. In the case described here, where 
hTBP binding to the TATA box results in an enhanced 
reactivity of pluramycin at a specific site downstream of 
the TATA box, which then immobilizes hTBP on 
DNA, one can propose at least two different biological 
consequences. First, the immobilization would lead to 
trapping ofTBP and associated transcriptional factors at 
transcription start sites where pluramycin is covalently 
bound. These sites would presumably be unproductive 
transcriptional regions, leading to down regulation of 
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Fig. 11. Molecular models of the plura- 
mycin-TBP-TATA-box complex. The 
structures were formed as described in 
Materials and methods. The ternary 
complex contains the following duplex 
DNA quence: 
V 
-(‘[~;:,r:;,.q:( :'I L" L :. ,-yy 
, ,( :: C" " ( ,‘.'.:.TIy?.'y'- (: I 
i: *(:m.‘c“I 'y: 
(' ,,c,r;.:.;:- '; 
h h 
whercl the arrows show phenylalanine 
insertions, the vertical line is the plura- 
mycin intercalation site, and C* shows 
the alkylated guaninc. (a) The minor- 
groove side of the pluramycin modifica- 
tion site on DNA. The sugar moieties of 
pluramycin (se<’ Fig. 1) interact in the 
minor groove, and the vinyl epoxidc 
flanks the I&hand side of the helix 
(pluramycin is shown in yellow). TBP is 
shown as a ribbon diagram (blue), 
except ior ~ys97 l:grecn), which after 
minimization H-bonds with a phos- 
phate and the 0acetyl group of plura- 
mycin. The N?alkylated guanine is 
shown in cyan. The DNA helix is shown 
in purplcx (bases), magenta idtoxyri- 
hoses), and gray (phosphates). (b) The 
major-groove side of the pluramycin 
modification guanine nucleotide 10 
showing the clear acccassibility of the 
pluramvcin-trappetl intercalation site 
from thi5 side. Colors as for (a). 
Significance 
The results of this study demonstrate that the spe- 
cific binding of hTBP to the TATA box creates a 
unique unwinding site immediately downstream 
of the TATA box that is trapped by the intercala- 
tive drug pluramycin, which alkylates N7 of 
guanine at the flanking site-These results demon- 
strate the utility of pluramycin as a specific probe 
for protein-induced unwinding sites where inter- 
calation may stabilize a specific binding mode of 
the protein-DNA complex. Based upon the com- 
patibility of intercalation by pluramycin with 
hTBP binding to the TATA box and the proposed 
structure of the ternary complex, which shows 
clear accessibility via the major-groove side to an 
unwound site downstream of the TATA box, we 
propose that this site may be a nucleation site for 
unwinding of DNA recognized by a transcription 
factor. A mechanism involving an asymmetric 
spring loading and the release of torque associated 
with binding and dissociation of TBP from the 
TATA box is used to rationalize the asymmetric 
distribution of pluramycin intercalation sites. The 
consequences of the immobilization of TBP at 
TATA boxes by pluramycin modification of a 
downstream site may have potent effects on trans- 
criptional control and lead to dramatic effects on 
cell survival. 
Materials and methods 
Materials 
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United States Biochemical. Pluramycin was kindly provided by 
Abbott Laboratories (Chicago, IL) and used in this study 
without further purification. A stock solution was prepared by 
dissolving pluramycin (1 mg) in 1 ml of methanol and diluting 
it with double-distilled water (DDW) just before carrying out 
each experiment.The oligonucleotides (64M and 64MI in Fig, 
2) were synthesized on an Applied Biosystems Model 380A 
oligonucleotide synthesizer and purified by polyacrylamide gel 
electrophoresis, as described before [ IFi], 
DNase I footprinting assay 
To form hTBP-DNA complexes, 5 ng of the 5’ end-labeled, 
64-bp double-stranded oligonucleotide was added to hTBP 
(final concentration 20 nM) in 20 (~1 of a solution containing 
25 mM Tris.HCl (pH 7.8), 50 mM KCl, 6.25 mM MgCl,, 
0.5 mM ethylenediaminetetraacetic acid (EDTA), 0.5 mM 
dithiothreitol (DTT), 0.01 % NP-40, and 5 ‘%I glycerol. After a 
30-min incubation at 37 “C, 100 ng of unlabeled 64-bp 
oligonucleotide was added, and the reaction w~as incubated for a 
further 10 min. Following treatment for 1 min with 0.2 U of 
DNase I, the reaction was terminated by the addition of 40 ~1 
of alkaline dye (80 o/o formamide, 10 mM NaOH) and then 
heated at 95 “C for 10 min. For measuring dissociation kinetics 
of the hTBP-DNA complex, 50 mg of DNA template was 
added to hTBP (final concentration 20 nM) in 200 ~1 of the 
same solution. After incubation for 30 min at 37 “C, 160 ~1 
portions of the reaction were removed and added to 2 pg of 
the unlabeled template DNA. At the indicated times, 20 ~1 of 
the reaction were withdrawn, and the extent of hTBP-DNA 
complex formation was analyzed by DNase I footprinting. In 
all cases, kinetic experiments were repeated at least twice to 
ensure reproducibility. 
Pluramycin protection experiments 
The hTBP-TATA-box complex was formed in 20 ~1 of solu- 
tion by incubating the reactions for 30 min at 37 “C, as 
described for the DNase I footprinting experiment. After the 
addition of 100 ng of unlabeled DNA, the reaction was incu- 
bated for a further 10 min, and the indicated amounts of plura- 
mycin were added to the reactions. Reaction with drug was 
continued for 5 min and stopped by adding 100 ~1 of DDW 
containing 10 kg of calf thymus DNA, followed by heating the 
reactions at 95 “C for 15 min to induce DNA strand breakage 
at the drug modification sites [15]. In some experiments, free 
drug molecules were removed by phenol/chloroform extrac- 
tion followed by ethanol precipitation. DNA pellets were dis- 
solved in 20 ~1 of 1 M piperidine solution, and samples were 
heated at 95 “C for 15 min to induce strand breakage at drug 
modification sites. Samples were lyophilized, redissolved in 20 
~1 of alkaline dye (80 o/o formamide and 10 mM NaOH), and 
then separated by electrophoresis on a 10 % sequencing gel at 
room temperature at 1400 V for 2 h. 
Formation of TBP-DNA complexes and the 
gel mobility shift assay 
The gel mobility shift assay was performed by binding hTBP 
to 64M in a buffer containing 25 mM Tris,HCl (pH 7.8), 
50 mM KCl, 6.25 mM MgCl,, 0.5 mM EDTA, 0.5 mM DTT, 
0.01 ‘Xl NP-40, and 5 ‘Xl glycerol. After incubation at 37 “C for 
30 min, a 20-molar excess of unlabeled 64M was added to the 
reaction, and the reactions were further incubated for the 
indicated period of time. Free and hTBP-bound DNA were 
separated on a 5 % polyacrylamide gel (3Y:l acrylamide/bis- 
acrylamidc) in Tris-borate-M&l2 (TBM) (50 mM Tris base, 
40 mM boric acid, 5 mM MgCl,) supplemented with 5 % 
glycerol. Gel electrophoresis was performed in TBM buf&r at 
4 “C for 4 h at 250 V. 
Determination of the dissociation kinetics of the 
TBP-DNA complex 
To prepare the 64bp oligonucleotide modified with plurd- 
mycin at the 3’-tide of the TATA box, 50 ng of 64M \va\ 
incubated with hTBP (final 20 nM) in 200 ~1 of binding 
buffer at 37 ‘C for 30 mm, and L>NA was modified with 
pluramycin (400 nM) for 5 min in the presence of hTBP. 
DNA was re-isolated by phenol/chloroform extraction fol- 
lowed by ethanol precipitation. hTBP-DNA complexes were 
reformed using this pluramycin-modified DNA by the incu- 
bation of the reaction mixture at 37 “C for 10 min followed 
by further incubation for 120 min. I)uring the incubation, a 
40 molar excess of unlabeled L1NA ~vas added to the reac- 
tion for the indicated period of time, and the amount of the 
specific hTBP-DNA complex was analyzed using J gel 
mobility shift assay. 
Cycliza tion experiments 
A 53-bp double-stranded oligonucleotide containing the 
TATA box sequence was used as a I)NA substrate for the 
cyclization experiment.This oligonucleotide was also designed 
to contain two Aj-tracts that are 16 bp away from the center 
of the TATA-box sequence to improve overall efficiency of 
cyclization (see Fig. IOd). The oligonucleotlde (2 ng) was 
labeled with [y-“‘P]ATP and was incubated for 30 min at 
37 ‘C with indicated amounts of hTBP in 20 ~1 of a ligate 
buffer.The ligation reaction was initiated by the addition of 
200 U ofT4 DNA ligase and incubated for 30 min.Thc effect 
of pluramycin modification on the efficiency of the formation 
of circular dimrrs was examined by adding pluramycin to the 
preformed hTBP-DNA complex prior to initiation of the lig- 
ation reaction. After ligation was complete, hTB1’ \VdS 
removed from the DNA substrate bv adding sodium dodecxl- 
sulfate to a 0.5 ‘Xl concentration and heating at 6.5 (1 for 
1.5 min. Ligated reaction products were separated by elec- 
trophoresis in a 6 ‘%I polyacrylamidc gel. Each band was then 
extracted from the gel, purified, and loaded onto a 3 ‘%I dena- 
turing polyacrylamide gel to determine the size of the DNA. 
according to the method described previously [30]. 
Generation of molecular models 
Molecular models were created by modif\iing the crystal struc- 
ture of the TBP-DNA complex. Flanking sequences were 
mutated and elongated to closely match sequences used in the gel 
studies, and pluramycin A was docked on the molecule using the 
program MIDAS [37] .The molecular model lvas then minimized 
ilz LJUC~LO usmg the molecular modeling package AMBER [38], 
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